FGP
Foyston, Gordon, & Payne Portfolio holdings
AUM
$439M
This Quarter Return
+0.97%
1 Year Return
+25.58%
3 Year Return
+78.33%
5 Year Return
+134.68%
10 Year Return
+224.6%
AUM
$576M
AUM Growth
+$576M
(+24%)
Cap. Flow
+$110M
Cap. Flow
% of AUM
19.17%
Top 10 Holdings %
Top 10 Hldgs %
51.94%
Holding
67
New
3
Increased
30
Reduced
21
Closed
4
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
$26.9M |
| 2 |
UnitedHealth
UNH
|
$24.3M |
| 3 |
Medtronic
MDT
|
$12.5M |
| 4 |
Novartis
NVS
|
$6.93M |
| 5 |
Microsoft
MSFT
|
$6.34M |
Top Sells
| 1 |
COL
Rockwell Collins
COL
|
$12.1M |
| 2 |
Bunge Global
BG
|
$3.79M |
| 3 |
Pfizer
PFE
|
$3.08M |
| 4 |
BHI
Baker Hughes
BHI
|
$2.64M |
| 5 |
Johnson Controls International
JCI
|
$2.41M |
Sector Composition
| 1 | Healthcare | 36.3% |
| 2 | Technology | 18.5% |
| 3 | Industrials | 13.86% |
| 4 | Financials | 12.79% |
| 5 | Consumer Staples | 7.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Johnson & Johnson
JNJ
$427B
| $53.4M | 9.27% | 410,775 +207,088 | +102% | +$26.9M |
|
|
2
Medtronic
MDT
$119B
| $43.8M | 7.61% | 563,720 +160,884 | +40% | +$12.5M |
|
|
3
Microsoft
MSFT
$3.77T
| $29.6M | 5.14% | 397,213 +85,176 | +27% | +$6.34M |
|
|
4
UnitedHealth
UNH
$281B
| $28.7M | 4.99% | 146,712 +123,886 | +543% | +$24.3M |
|
5
Aon
AON
$79.1B
| $27.8M | 4.83% | 190,602 +40,364 | +27% | +$5.9M |
|
|
WBA
6
DELISTED
Walgreens Boots Alliance
WBA
| $27.7M | 4.81% | 358,794 +37,006 | +12% | +$2.86M |
|
7
Oracle
ORCL
$635B
| $26M | 4.51% | 537,166 +99,588 | +23% | +$4.82M |
|
8
Wells Fargo
WFC
$263B
| $21.8M | 3.79% | 396,178 +35,453 | +10% | +$1.96M |
|
9
American Express
AXP
$231B
| $20.8M | 3.6% | 229,473 +64,199 | +39% | +$5.81M |
|
10
RTX Corp
RTX
$212B
| $19.5M | 3.39% | 168,388 +44,502 | +36% | +$5.17M |
|
11
Union Pacific
UNP
$133B
| $18.9M | 3.28% | 162,787 +37,297 | +30% | +$4.33M |
|
12
Motorola Solutions
MSI
$78.7B
| $16.4M | 2.84% | 192,974 +32,770 | +20% | +$2.78M |
|
13
PepsiCo
PEP
$204B
| $15.7M | 2.72% | 140,697 -309 | -0.2% | -$34.4K |
|
|
14
Novartis
NVS
$245B
| $14.4M | 2.5% | 167,723 +80,693 | +93% | +$6.93M |
|
15
Cisco
CSCO
$274B
| $13.9M | 2.42% | 414,730 +93,960 | +29% | +$3.16M |
|
16
Baxter International
BAX
$12.7B
| $12.5M | 2.17% | 198,804 +37,137 | +23% | +$2.33M |
|
17
Gentex
GNTX
$6.15B
| $12M | 2.08% | 605,501 +231,045 | +62% | +$4.57M |
|
18
Check Point Software Technologies
CHKP
$20.7B
| $11.5M | 1.99% | 100,540 +34,187 | +52% | +$3.9M |
|
|
TFCFA
19
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $11.3M | 1.97% | 429,246 +126,533 | +42% | +$3.34M |
|
|
20
Pfizer
PFE
$141B
| $11.1M | 1.93% | 311,002 -86,292 | -22% | -$3.08M |
|
|
21
Johnson Controls International
JCI
$69.9B
| $9.9M | 1.72% | 245,724 -59,908 | -20% | -$2.41M |
|
22
W.W. Grainger
GWW
$48.5B
| $9.14M | 1.59% | 50,864 +14,054 | +38% | +$2.53M |
|
23
Novo Nordisk
NVO
$251B
| $8.26M | 1.43% | 171,472 +56,941 | +50% | +$2.74M |
|
24
C.H. Robinson
CHRW
$15.2B
| $6.56M | 1.14% | 86,211 +1,972 | +2% | +$150K |
|
25
L3Harris
LHX
$51.9B
| $5.69M | 0.99% | 43,231 +13,169 | +44% | +$1.73M |
|